These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10829930)

  • 1. Effect of gender, birth weight and gestational age on serum 17-hydroxyprogesterone concentration and distribution among neonates in Saudi Arabia.
    al-Nuaim AR; Abdullah MA; Stevens B; Zain M
    Indian J Pediatr; 1995; 62(5):605-9. PubMed ID: 10829930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
    Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
    Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P; Camilot M; Teofoli F; Tatò L
    Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
    González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
    Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
    van der Kamp HJ; Oudshoorn CG; Elvers BH; van Baarle M; Otten BJ; Wit JM; Verkerk PH
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3904-7. PubMed ID: 15797960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
    Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal screening for congenital adrenal hyperplasia.
    Barra CB; Silva IN; Pezzuti IL; Januário JN
    Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
    Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of factors associated with elevated newborn 17-hydroxyprogesterone levels.
    Anandi VS; Shaila B
    J Pediatr Endocrinol Metab; 2017 May; 30(6):677-681. PubMed ID: 28489558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol.
    Gruñeiro-Papendieck L; Prieto L; Chiesa A; Bengolea S; Bossi G; Bergadá C
    Horm Res; 2001; 55(6):271-7. PubMed ID: 11805430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
    Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
    Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
    Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
    Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
    Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia.
    King JL; Naber JM; Hopkin RJ; Repaske DR; Bailey L; Leslie ND
    Arch Pediatr Adolesc Med; 2001 Sep; 155(9):1038-42. PubMed ID: 11529806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital.
    Chennuri VS; Mithbawkar SM; Mokal RA; Desai MP
    Indian J Pediatr; 2013 Jan; 80(1):21-5. PubMed ID: 22865354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina.
    Gruñieiro-Papendieck L; Chiesa A; Mendez V; Prieto L
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):73-8. PubMed ID: 18404975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.
    Olgemöller B; Roscher AA; Liebl B; Fingerhut R
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5790-4. PubMed ID: 14671170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal screening for congenital adrenal hyperplasia.
    van der Kamp HJ; Wit JM
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U71-5. PubMed ID: 15554889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of clinical associations with 17-hydroxyprogesterone in preterm newborns.
    Ryckman KK; Cook DE; Berberich SL; Shchelochkov OA; Berends SK; Busch T; Dagle JM; Murray JC
    J Pediatr Endocrinol Metab; 2012; 25(3-4):301-5. PubMed ID: 22768660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.